The company is a small team of investors, entrepreneurs, operators, clinicians, scientists and technologists, supported by a board of healthcare and life sciences leaders and an investment committee of experienced venture investors and innovators.
KHP Ventures is raising a £20 million fund to invest in startups addressing depression, anxiety and psychosis, with investments ranging from £250,000 to £1 million. Wellcome anchors the fund with an £8 million commitment, and the fund expects to close in early 2025. Investee startups can receive help with clinical trials, patient and service data access, and testing products in live settings.
Apian, Alphabet’s Wing, and the NHS plan a six-month pilot using drones to transport urgent blood samples between Guy’s Hospital and St Thomas’ Hospital in London. The flights serve surgery patients at high risk of bleeding complications, cutting deliveries that take vans or motorbikes more than 30 minutes to less than two minutes, according to officials. The Civil Aviation Authority oversees the airspace, and a similar trial for blood platelets is also planned.
Sep 2024 · TechCrunchNews article
KHP Ventures
Operating Status: Operating
KHP Ventures: An investment firm innovating in healthcare solutions.
